Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Denis, Maillet"'
Autor:
Antonio Farina, Macarena Villagrán-García, Anthony Fourier, Anne-Laurie Pinto, Fatima Chorfa, Noémie Timestit, Tifanie Alberto, Jérôme Aupy, Marie Benaiteau, Cristina Birzu, Lucia Campetella, François Cotton, Stéphane Dalle, Clara Fontaine Delaruelle, Pauline Dumez, Rafaele Germi, Marion Le Maréchal, Denis Maillet, Romain Marignier, Antoine Pegat, Dimitri Psimaras, Marie Rafiq, Géraldine Picard, Virginie Desestret, Isabelle Quadrio, Jérôme Honnorat, Bastien Joubert
Publikováno v:
The Lancet Regional Health. Europe, Vol 44, Iss , Pp 101011- (2024)
Summary: Background: Immune checkpoint inhibitor-related encephalitis (ICI-encephalitis) is not well characterised and diagnostic and prognostic biomarkers are lacking. We aimed to comprehensively characterise ICI-encephalitis and identify diagnostic
Externí odkaz:
https://doaj.org/article/507817f9fd4a4e77b37288ae6e2b16c1
Autor:
Cedric Pobel, Edouard Auclin, Diego Teyssonneau, Brigitte Laguerre, Mathilde Cancel, Elouen Boughalem, Johanna Noel, Pierre Emmanuel Brachet, Denis Maillet, Philippe Barthelemy, Carole Helissey, Constance Thibault, Stéphane Oudard
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6304-6309 (2021)
Abstract Introduction Cabazitaxel multiple rechallenges may be a treatment option in heavily pretreated patients with metastatic castration‐resistant prostate cancer (mCRPC) who had a good initial response to cabazitaxel and who are still fit to re
Externí odkaz:
https://doaj.org/article/8128dd4e4685494fb649da182fb87d96
Autor:
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Publikováno v:
Biomedicines, Vol 11, Iss 1, p 83 (2022)
Background: ICIs have dramatically improved patient outcomes in different malignancies. However, the impact of liver metastases (LM) and number of metastatic sites (MS) remains unclear in patients treated with single-agent anti-PD(L)1. Methods: We ai
Externí odkaz:
https://doaj.org/article/e7cc979200244e72838dc3ed0a64b7ec
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2758 (2022)
(1) Background: Ipilimumab plus nivolumab (combo-ICI) improves overall survival (OS) in patients with advanced renal cell carcinoma (RCC) or melanoma. The impact of bone metastases (BM) on survival outcomes of combo-ICI-treated patients is unknown. (
Externí odkaz:
https://doaj.org/article/ceb78ca345154996bec76ec69464ecde
Autor:
Alicja Puszkiel, Benoit You, Léa Payen, Jonathan Lopez, Jérôme Guitton, Pascal Rousset, Juliette Fontaine, Julien Péron, Denis Maillet, Sophie Tartas, Nathalie Bonnin, Veronique Trillet-Lenoir, Olivier Colomban, Diane Augu-Denechere, Gilles Freyer, Michel Tod
Publikováno v:
Cancer Chemotherapy and Pharmacology. 91:413-425
Autor:
Denis Maillet, Benjamin Rémy
Publikováno v:
Heat Transfer Engineering. :1-17
Autor:
Romain Varnier, Alicja Puszkiel, Michel Tod, Sara Calattini, Lea Payen, Jonathan Lopez, Jérome Guitton, Vérane Schwiertz, Juliette Fontaine, Julien Peron, Denis Maillet, Sophie Tartas, Nathalie Bonnin, Olivier Colomban, Diane Augu-Denechere, Gilles Freyer, Benoit You
Publikováno v:
Cancer Chemotherapy and Pharmacology. 91:361-373
Autor:
Bernadett Szabados, Mark Kockx, Zoe June Assaf, Pieter-Jan van Dam, Alejo Rodriguez-Vida, Ignacio Duran, Simon J. Crabb, Michiel S. Van Der Heijden, Albert Font Pous, Gwenaelle Gravis, Urbano Anido Herranz, Andrew Protheroe, Alain Ravaud, Denis Maillet, Maria Jose Mendez, Cristina Suarez, Mark Linch, Aaron Prendergast, Charlotte Tyson, Diana Stanoeva, Sofie Daelemans, Miche Rombouts, Sanjeev Mariathasan, Joy S. Tea, Kelly Mousa, Shruti Sharma, Alexey Aleshin, Romain Banchereau, Daniel Castellano, Thomas Powles
Publikováno v:
European urology
[Background] Neoadjuvant immunotherapies hold promise in muscle-invasive bladder cancer (MIBC).
[Objective] To report on 2-yr disease-free (DFS) and overall (OS) survival including novel tissue-based biomarkers and circulating tumor DNA (ctDNA)
[Objective] To report on 2-yr disease-free (DFS) and overall (OS) survival including novel tissue-based biomarkers and circulating tumor DNA (ctDNA)
Autor:
Florence Joly, Jean-Marie Michot, Louis Marie Dourthe, Aude Fléchon, Hakim Mahammedi, Denis Maillet, Guillaume Mouillet, Damien Pouessel, Frédéric Rolland, Delphine Topart, Laurence Albiges
Publikováno v:
Bulletin du Cancer. 109:844-861
Autor:
Stéphane Oudard, Brigitte Laguerre, Carole Helissey, Mathilde Cancel, Diego Teyssonneau, Pierre Emmanuel Brachet, Edouard Auclin, Constance Thibault, Philippe Barthélémy, Johanna Noel, Cedric Pobel, Denis Maillet, Elouen Boughalem
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6304-6309 (2021)
Cancer Medicine
Cancer Medicine
Introduction Cabazitaxel multiple rechallenges may be a treatment option in heavily pretreated patients with metastatic castration‐resistant prostate cancer (mCRPC) who had a good initial response to cabazitaxel and who are still fit to receive it.